Timing is Everything: Early Chemotherapy Boosts Colorectal Cancer Survival
Study finds starting chemotherapy within 6 weeks after colorectal cancer surgery improves survival rates.
Breast Cancer
22 articles
DESTINY-Breast06 Trial: Trastuzumab Deruxtecan Shows Promise in HER2-Low Breast Cancer
Trastuzumab deruxtecan outperforms chemotherapy in HER2-low metastatic breast cancer clinical trial.
T-DXd Shows Promising Results for HER2+ Breast Cancer with Brain Metastases
Large trial demonstrates T-DXd's efficacy in treating HER2+ breast cancer with brain metastases.
Long-Term Study Confirms T-DM1's Superiority in HER2+ Breast Cancer Treatment
T-DM1 shows significant improvement in overall survival for HER2+ early breast cancer patients.
Pembrolizumab Boosts Survival in Early-Stage Triple-Negative Breast Cancer: KEYNOTE-522 Final Results
Pembrolizumab plus chemotherapy improves overall survival in early-stage triple-negative breast cancer.
Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
NOBROLA Trial: Olaparib Shows Promise in Rare TNBC Subset Despite Low Enrollment
Phase II trial explores olaparib in TNBC patients with HRD but no BRCA mutations, showing potential benefit.
Unmasking the Risk Factors: New Insights into Immune-Mediated Hepatotoxicity in Cancer Immunotherapy
Meta-analysis reveals key risk factors for liver toxicity in cancer patients receiving immunotherapy
Intensified Chemo Falls Short in Oligometastatic Breast Cancer Study
IACT shows no advantage over CDCT in HRD-positive oligometastatic breast cancer, but long-term survival promising
Neoadjuvant Endocrine Therapy Reduces Mastectomy Rates in Early Breast Cancer
Meta-analysis shows neoadjuvant endocrine therapy lowers mastectomy rates in ER-positive early breast cancer.
Genetic Variants Linked to Higher Mortality Risk in Cancer Chemotherapy
Meta-analysis reveals DPYD gene variants significantly increase death risk in fluoropyrimidine chemotherapy.
Acupressure: A Promising Complementary Therapy for Chemotherapy-Induced Nausea in Breast Cancer
Study shows acupressure reduces chemotherapy-induced nausea and vomiting in breast cancer patients.
Promising Brain Breakthrough: T-DXd Shows Hope for HER2-Low Breast Cancer with Brain Metastases
T-DXd demonstrates encouraging intracranial activity in HER2-low breast cancer patients with brain metastases.